Evaluating the Therapeutic Potential of Idecabtagene Vicleucel in the Treatment of Multiple Myeloma: Evidence to Date

Over the past two decades, significant progress has been made in the diagnosis, risk assessment and treatment of patients with multiple myeloma, translating into remarkable improvements in survival outcomes. Yet, cure remains elusive, and almost all patients eventually experience relapse, particular...

Descripción completa

Detalles Bibliográficos
Autores principales: Mann, Hashim, Comenzo, Raymond L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327779/
https://www.ncbi.nlm.nih.gov/pubmed/35912273
http://dx.doi.org/10.2147/OTT.S305429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327779/
https://www.ncbi.nlm.nih.gov/pubmed/35912273
http://dx.doi.org/10.2147/OTT.S305429

Ejemplares similares